Parallel Advisors
ACHV icon

Parallel Advisors’s Achieve Life Sciences ACHV Stock Holding History

Parallel Advisors’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$680 Buy
+84
New +$601 ﹤0.01% 3846

Other funds holding ACHV

Simplify Asset Management
Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return
Blue Trust Inc
Blue Trust Inc Alpharetta, Georgia $9.5B AUM 13.02% 1-Year Est. Return
Manchester Financial
Manchester Financial Westlake Village, California $565M AUM 15.04% 1-Year Est. Return
Prospera Financial Services
Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return
Members Wealth
Members Wealth Media, Pennsylvania $200M AUM 9.84% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Parallel Advisors's ACHV Position: Q3 2026 in Review

Parallel Advisors opened a new position in Achieve Life Sciences (ACHV) in Q3 2026: 84 shares worth $680. The stake represents ﹤0.01% of the portfolio and ranks #3846 among its holdings.

23 funds tracked by Wall St. Rank hold ACHV as of Q3 2026.

  • Parallel Advisors held 84 shares of Achieve Life Sciences worth $680 as of Q3 2026.
  • Achieve Life Sciences was a new Parallel Advisors position in Q3 2026.
  • Achieve Life Sciences made up ﹤0.01% of Parallel Advisors's portfolio in Q3 2026, its #3846 holding.
  • 23 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2026.

Based on Parallel Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.